Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/IXC stock hub

ASX/IXC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/IXCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.8M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/IXC

In the news

Latest news · ASX/IXC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-16.8

P25 -118.7P50 -49.4P75 -1.2

ROIC-13.6

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/IXC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

149

Groups with data

Currency

AUD

Showing 149 of 149 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 5.2M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU0000048621
Last refreshed	2026-05-10
Market cap	AUD 9.8M
Price	AUD 0.13
Price currency	AUD
Sector	Healthcare
Sic	2834
Symbol	asx/IXC
Website	https://www.invextherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.56%
EV Earnings	-6.19x
EV/Sales	22.59x
P/B ratio	2.15x
P/S ratio	42.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	AUD 229,084
Gross Profit Growth	0%
Gross Profit Growth3 Y	-42.61%
Gross Profit Growth5 Y	-12.98%
Net Income	AUD -835,915
Net Income Growth Years	2%
Pretax Margin	-364.89%
ROA	-12.75
Roa5y	-10.11
ROCE	-23.76
ROE	-16.83
Roe5y	-14.65
ROIC	-13.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	62.55%
Cagr3y	4.66%
Cagr5y	-6.66%
EPS Growth Years	2
Revenue Growth	-81.1x
Revenue Growth Years	0x
Revenue Growth3 Y	-42.61x
Revenue Growth5 Y	-12.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.04
Assets	AUD 4.7M
Cash	AUD 4.6M
Current Assets	AUD 4.7M
Current Liabilities	AUD 176,488
Equity	AUD 4.5M
Liabilities	AUD 176,488
Long Term Assets	AUD 0
Long Term Liabilities	AUD 0
Net Cash	AUD 4.6M
Net Cash By Market Cap	AUD 47.04
Net Cash Growth	-20.86%
Net Debt Equity	AUD -1.01
Tangible Book Value	AUD 4.5M
Tangible Book Value Per Share	AUD 0.06
WACC	7.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	26.76
Net Working Capital	AUD -48,493
Quick ratio	26.76
Working Capital	AUD 4.5M
Working Capital Turnover	AUD 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.3%
Dividend per share	AUD 0
Last Dividend	AUD 0.19

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	62.5%
200-day SMA	0.1
3Y total return	14.65%
50-day SMA	0.11
50-day SMA vs 200-day SMA	50over200
5Y total return	-29.14%
All Time High	2.05
All Time High Change	-93.66%
All Time High Date	2020-05-22
All Time Low	0.06
All Time Low Change	120.34%
All Time Low Date	2025-03-13
ATR	0
Beta	0.54
Beta1y	-0.68
Beta2y	-0.19
Ch YTD	8.33
High	0.13
High52	0.18
High52 Date	2025-09-23
High52ch	-27.78%
Low	0.13
Low52	0.08
Low52 Date	2025-08-13
Low52ch	73.33%
Ma50ch	13.64%
Price vs 200-day SMA	26.83%
RSI	64.78
RSI Monthly	47.86
RSI Weekly	57.4
Sharpe ratio	1.02x
Sortino ratio	1.83
Total Return	0.3%
Tr YTD	8.33
Tr1m	30%
Tr3m	4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -1.1M
Operating margin	-471.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,677,206%
Shares Insiders	28.04%
Shares Institutions	21.05%
Shares Out	75,153,848
Shares Qo Q	-0.27%
Shares Yo Y	-0.3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	37,258.35x
Bv Per Share	0.06
Ch1m	30
Ch1y	62.5
Ch3m	4
Ch3y	-70.79
Ch5y	-81.94
Ch6m	13.04
Change	0%
Change From Open	0
Close	0.13
Days Gap	0
Dollar Volume	910
Earnings Date	2026-05-13
EBIT	AUD -1.1M
EPS	AUD -0.01
F Score	2
Fiscal Year End	June
Founded	2,019
Is Primary Listing	1
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Ma150	0.11
Ma150ch	16.18%
Ma20	0.11
Ma20ch	22.64%
Net CF	-1,211,131
Next Earnings Date	2026-05-13
Open	0.13
Price Date	2026-05-06
Ptbv Ratio	2.15
Relative Volume	0.19x
Revenue	229,084x
SBC By Revenue	7.11x
Share Based Comp	16,295
Tr6m	13.04%
Volume	7,000
Z Score	19.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/IXC pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/IXC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/IXC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.1%

Share of float held by funds and institutions

Insider ownership

+28.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

ASX/IXC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.8

Neutral momentum band

Price vs 200-day MA

+26.8%

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/IXC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/IXC stock rating?

asx/IXC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/IXC analysis?

The full report lives at /stocks/asx/IXC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/IXC?

The latest report frames asx/IXC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/IXC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.